Biography
Cormac is Private Equity Counsel in Weil’s London office. He advises leading private capital sponsors and other institutional investors on a wide range of complex multi-jurisdictional transactions across asset classes including acquisitions and disposals, take-private transactions, complex carve-outs, GP-led recapitalisations, structured liquidity transactions, preferred equity, minority investments, and joint ventures.
He also has experience advising private equity sponsors and their portfolio companies on a wide range of corporate advisory work, including corporate restructurings and other portfolio management solutions and governance matters.
Representative experience as part of a team, including prior to joining Weil, includes:
- HarbourVest Partners as a lead investor on its investment in Inflexion’s £2.3 billion multi-asset continuation fund which, at the date of closing, was the largest multi-asset continuation fund raised in Europe to date
- Sovereign investors and large institutional investors on structuring, negotiation and documentation of all stages of secondary transactions, including GP-led recapitalizations, secondary purchases and sales, and other structured liquidity transactions
- Regularly advising sovereign investors and other institutional investors (including pension funds) in co-investment transactions
- Bain Capital on its sale of the Zellis group to Apax Partners, valuing Zellis at £1.25 billion
- Funds advised by Permira on their approximately $5.8 billion acquisition of Mimecast
- AEA Investors on its sale of a majority stake in Scan Global Logistics as part of a deal valued at approximately $1.5 billion
- Liberty Global Ventures on its joint venture arrangements with InfraVia Capital Partners in connection with greenfield development of fibre-to-the-home (FTTH) broadband infrastructure across certain underserved German municipalities
- Francisco Partners on its sale of LiveU to funds advised by the Carlyle Group
- Funds advised by Clayton, Dubilier & Rice, LLC on the £2.8 billion acquisition of UDG Healthcare
- Fenergo Limited and its shareholders on its sale to funds advised by Bridgepoint and Astorg